*Composite primary end point.
†Two separate publications based on the same study.
ACR, American College of Rheumatology; CRP, C reactive protein; csDMARD, conventional synthetic disease-modifying antirheumatic drug; DAS, Disease Activity Score; i.a., intra-articular; MR, modified release; p.o., per os; RA, rheumatoid arthritis; RoB, risk of bias.